Clinical trial

Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients…

NCT00020345 · National Institutes of Health Clinical Center (CC), NIH · Completed

Key facts

NCT number NCT00020345
Title Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
Official title Phase II Study of Neoadjuvant Intraperitoneal Gemcitabine and Intravenous Gemcitabine With Radiotherapy Followed by Surgery and Adjuvant Intraperitoneal Gemcitabine, Intravenous Gemcitabine, and Fluorouracil in Patients With Advanced Adenocarcinoma of the Pancreas
Lead sponsor National Institutes of Health Clinical Center (CC), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Stage IVA Pancreatic Cancer, Stage III Pancreatic Cancer, Adenocarcinoma of the Pancreas
Intervention type Drug
Interventions fluorouracil, gemcitabine
Start date Sep 1, 2000
Completion Mar 1, 2002
First posted Mar 6, 2007
Last update posted Oct 31, 2023
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies